Showing 5821-5830 of 10627 results for "".
- High or Low Oxygen Levels Are Safe During Heart Surgery: Studyhttps://reachmd.com/news/high-or-low-oxygen-levels-are-safe-during-heart-surgery-study/2467909/Two out of 10 people who receive cardiac surgery are affected by acute kidney injury, prolonging their hospital stay and increasing their risk for chronic kidney disease, cognitive decline and heart failure. A Vanderbilt University Medical Center study explored one possible cause — hype
- Surgical Method Developed in Leipzig for the Treatment of Cervical Cancer Offers Advantages Over Standard Treatmenthttps://reachmd.com/news/surgical-method-developed-in-leipzig-for-the-treatment-of-cervical-cancer-offers-advantages-over-standard-treatment/2467405/Cervical cancer is the fourth most common malignant tumour in women worldwide. In the early stages, surgery can be of benefit to most patients. In a comparative study including more than 1000 patients with more than 10 years of follow-up, the standard treatment for this cancer has now
- Meditating with Headband That Tracks Brain Activity May Improve Surgical Recovery in Patients with Cushing’shttps://reachmd.com/news/meditating-with-headband-that-tracks-brain-activity-may-improve-surgical-recovery-in-patients-with-cushings/2466925/Newswise — BOSTON—Patients with Cushing’s syndrome who are recovering from surgery and wear a headband that tracks brain activity while they meditate may have less pain and better physical functioning compared with patients not using the device, suggests a study
- Op-Ed: 10 Early Lessons that Shaped My Money Philosophyhttps://reachmd.com/news/op-ed-10-early-lessons-that-shaped-my-money-philosophy/2457400/We all learned things about money growing up, whether intentionally or not. Does what we learned in childhood matter to our financial lives once we come of age? Raised by an ultra-frugal dad and a joyful spender of a mom, I appreciate what I’ve learned from each approach. Here are ten earl
- Protein Levels in Plasma Highly Predictive of Future Dementia Risk According to UK Biobank Studyhttps://reachmd.com/news/protein-levels-in-plasma-highly-predictive-of-future-dementia-risk-according-to-uk-biobank-study/2457313/People with higher baseline plasma levels of certain proteins, including glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), growth/differentiation factor 15 (GDF15), and latent-transforming growth factor beta-binding protein 2 (LTBP2), had an elevated risk of d
- SCAI Publishes Expert Consensus Statement on Management of Calcified Coronary Lesions Requiring Interventionhttps://reachmd.com/news/scai-publishes-expert-consensus-statement-on-management-of-calcified-coronary-lesions-requiring-intervention/2457068/January 31, 2024 — Coronary artery calcification is increasing in prevalence, leading to greater risks both during pro
- Early and Sustained Depemokimab Efficacy in Type 2 Asthmahttps://reachmd.com/news/early-and-sustained-depemokimab-efficacy-in-type-2-asthma/2486867/Key Takeaways Depemokimab was associated with fewer first exacerbations than placebo over 52 weeks, and benefit appeared by week 4. Improvements were reported across each 26-week dosing period in symptom and quality-of-life measures, with sustained res
- AAD 2026: Revance to Showcase Expanding Aesthetics Portfoliohttps://reachmd.com/news/aad-2026-revance-to-showcase-expanding-aesthetics-portfolio/2486383/Revance Therapeutics Inc. announced it will showcase its expanding portfolio of aesthetics, regenerative medicine, and consumer skincare products at the 2026 American Academy of Dermatology (AAD) Annual Meeting, scheduled for March 26–31 in Denver, Colorado. The company plans a series of in-booth
- AAD 2026: Acclaro to Highlight Expanding Clinical Uses of UltraClear 2910 nm Fiber Laserhttps://reachmd.com/news/aad-2026-acclaro-to-highlight-expanding-clinical-uses-of-ultraclear-2910-nm-fiber-laser/2486381/Emerging clinical data on Acclaro’s UltraClear® 2910 nm fiber laser is set to be presented during multiple sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado from March 26 through 31. The technology, a cold ablative fiber lase
- Sanofi to Present Data on Dupilumab for BP, AD, CSU, PN, Plus Amlitelimabhttps://reachmd.com/news/Sanofi-Present-Data-Dupilumab-BP-AD-CSU-PN-Plus-Amlitelimab/2471384/Sanofi will present 26 abstracts, including one late-breaking and five additional oral presentations, across approved and investigational medicines at the American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, from March 7-11. Presentations in partnership with Regeneron